These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33496649)

  • 1. SARS-CoV-2 Infection and Mitigation Efforts among Office Workers, Washington, DC, USA.
    Sami S; Vuong N; Miller H; Priestley R; Payne M; Licata-Portentoso G; Drobeniuc J; Petersen LR
    Emerg Infect Dis; 2021 Feb; 27(2):669-672. PubMed ID: 33496649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.
    Selvaraju S; Kumar MS; Thangaraj JWV; Bhatnagar T; Saravanakumar V; Kumar CPG; Sekar K; Ilayaperumal E; Sabarinathan R; Jagadeesan M; Hemalatha MS; Murhekar MV;
    Emerg Infect Dis; 2021 Feb; 27(2):586-589. PubMed ID: 33496222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
    Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
    Shrotri M; Harris RJ; Rodger A; Planche T; Sanderson F; Mahungu T; McGregor A; Heath PT; ; Brown CS; Dunning J; Hopkins S; Ladhani S; Chand M
    Emerg Infect Dis; 2021 Apr; 27(4):1155-1158. PubMed ID: 33734962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment.
    Norsa L; Cosimo P; Indriolo A; Sansotta N; D'Antiga L; Callegaro A
    Gastroenterology; 2020 Dec; 159(6):2229-2231.e2. PubMed ID: 32860790
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units.
    Haizler-Cohen L; Davidov A; Blitz MJ; Fruhman G
    Am J Obstet Gynecol; 2021 Jan; 224(1):112-114. PubMed ID: 32971014
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
    PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
    Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
    Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 in first trimester pregnancy: a cohort study.
    la Cour Freiesleben N; Egerup P; Hviid KVR; Severinsen ER; Kolte AM; Westergaard D; Fich Olsen L; Prætorius L; Zedeler A; Christiansen AH; Nielsen JR; Bang D; Berntsen S; Ollé-López J; Ingham A; Bello-Rodríguez J; Storm DM; Ethelberg-Findsen J; Hoffmann ER; Wilken-Jensen C; Jørgensen FS; Westh H; Jørgensen HL; Nielsen HS
    Hum Reprod; 2021 Jan; 36(1):40-47. PubMed ID: 33145598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020.
    Letizia AG; Ge Y; Goforth CW; Weir DL; Lizewski R; Lizewski S; Soares-Schanoski A; Vangeti S; Marjanovic N; Sealfon SC; Ramos I
    Emerg Infect Dis; 2021 Apr; 27(4):1188-1192. PubMed ID: 33529569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
    Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
    J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
    Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
    Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA.
    Feehan AK; Velasco C; Fort D; Burton JH; Price-Haywood EG; Katzmarzyk PT; Garcia-Diaz J; Seoane L
    Emerg Infect Dis; 2021 Nov; 27(1):314-7. PubMed ID: 33171096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies as a Serologic Marker of Infection in Patients With Coronavirus Disease 2019.
    Rongqing Z; Li M; Song H; Chen J; Ren W; Feng Y; Gao GF; Song J; Peng Y; Su B; Guo X; Wang Y; Chen J; Li J; Sun H; Bai Z; Cao W; Zhu J; Zhang Q; Sun Y; Sun S; Mao X; Su J; Chen X; He A; Gao W; Jin R; Jiang Y; Sun L
    Clin Infect Dis; 2020 Nov; 71(16):2066-2072. PubMed ID: 32357209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.